The pharmacological inhibition of FATP2 by lipofermata resulted in a delay in tumor growth of mice bearing different and etiologically unrelated tumors (namely: LLC and EL4), without affecting the proliferation of the same tumors cultured in vitro (Figure 1C). This evidence concerns the gene SLC27A2 and neoplasm.